Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 priming

Cecilie Bo Hansen*, Ida Jarlhelt, Rasmus Bo Hasselbalch, Sebastian Rask Hamm, Kamille Fogh, Mia Marie Pries-Heje, Dina Leth Møller, Line Dam Heftdal, Laura Pérez-Alós, Erik Sørensen, Margit Anita Hørup Larsen, Mikkel-Ole Skjoedt, Sisse Rye Ostrowski, Ruth Frikke-Schmidt, Rafael Bayarri-Olmos, Linda Maria Hilsted, Henning Bundgaard, Susanne Dam Nielsen, Kasper Karmark Iversen, Peter Garred

*Corresponding author for this work
11 Citations (Scopus)
Original languageEnglish
JournalJournal of Internal Medicine
Volume290
Issue number6
Pages (from-to)1272-1274
Number of pages3
ISSN0954-6820
DOIs
Publication statusPublished - Dec 2021

Keywords

  • antibody neutralization
  • antibody response
  • BNT162b2
  • COVID-19
  • IgA
  • IgG
  • IgM
  • immunoassays
  • nucleocapsid protein
  • RBD
  • SARS-CoV-2
  • serology
  • vaccine

Cite this